NCT07246824 Expanding Access to Safe Water in Nigeria
| NCT ID | NCT07246824 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Chlorination |
| Study Type | INTERVENTIONAL |
| Enrollment | 700 participants |
| Start Date | 2025-09-30 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 700 participants in total. It began in 2025-09-30 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Access to safe water remains a pressing public health challenge in Nigeria, where 67% of the population lacks safely managed drinking water and waterborne diseases cause an estimated 70,000 child deaths annually. Building on evidence that point-of-use chlorination is highly cost-effective in reducing diarrheal disease, this study evaluates a scalable, community-based chlorine distribution model through a cluster-randomized controlled trial (RCT) in Kano State. Thirty communities across four Local Government Areas will be randomly assigned to one of three groups: (i) 20 treatment communities receiving community demonstrations and local chlorine redemption points, (ii) 10 control communities where no intervention will be conducted. After 3 months, 5 control communities will receive an individual-level sensitization and a voucher program and 5 will remain pure control communities. The RCT aims to estimate the causal impact of the community-based intervention on household chlorination rates, water quality (E. coli contamination), and knowledge of safe water practices over six months. By rigorously testing a community-led water treatment model, this study contributes new evidence on sustainable and cost-effective approaches to expand safe water access in low-resource settings. The results will inform national and regional strategies for scaling point-of-use chlorination across sub-Saharan Africa.
Eligibility Criteria
Inclusion Criteria: * Pregnant mothers and women with children under 5 children Exclusion Criteria: * Men, women with no children under 5 years old
Contact & Investigator
Elisa Maria Maffioli, PhD
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT07246824 clinical trial?
This trial is open to female participants only, studying Chlorination. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07246824 currently recruiting?
Yes, NCT07246824 is actively recruiting participants. Contact the research team at elisamaf@umich.edu for enrollment information.
Where is the NCT07246824 trial being conducted?
This trial is being conducted at Kano, Nigeria.
Who is sponsoring the NCT07246824 clinical trial?
NCT07246824 is sponsored by University of Michigan. The principal investigator is Elisa Maria Maffioli, PhD at University of Michigan. The trial plans to enroll 700 participants.